Fresenius Targets Nostrum's Generic PhosLo GelCaps
Fresenius Medical Care Holdings Inc. on Friday lodged a patent infringement suit in Massachusetts federal court in an effort to block Nostrum Laboratories Inc. from marketing a generic version of kidney...To view the full article, register now.
Already a subscriber? Click here to view full article